Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study: Figure 1

Autor:	Thomas Zoller, M. Develoux, Thierry Rolling, Mirjam Schunk, Matthias Schmid, Michael Ramharter, Antoni Soriano-Arandes, Matthieu Mechain, Peter Pongratz, Spinello Antinori, Joaquín Salas-Coronas, Joaquim Gascon, Florian Kurth, Emanuele Nicastri, Guido Calleri, José Saraiva da Cunha, Henrik Nielsen, Pietro Antonini, Andreas Neumayr, Christoph Hatz, Kristine Mørch, Gudrun Just-Nübling, Ida Gjørup, Anna Hachfeld, Philipp Zanger, Alessandro Bartoloni, Peter Kern, Jan Clerinx, Norbert Suttorp, Leo G. Visser
Rok vydání:	2015
Předmět:	Microbiology (medical) medicine.medical_specialty macromolecular substances law.invention chemistry.chemical_compound Randomized controlled trial law Intensive care parasitic diseases medicine Severe Malaria Intensive care medicine Quinine biology business.industry musculoskeletal neural and ocular physiology Plasmodium falciparum biology.organism_classification Intensive care unit Clinical trial Infectious Diseases nervous system chemistry Artesunate Emergency medicine business medicine.drug
Zdroj:	Clinical Infectious Diseases. 61:1441-1444
ISSN:	1537-6591 1058-4838
Popis:	Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6f6b7f82ca96906747e2d6d720e3cb56 https://doi.org/10.1093/cid/civ575 Zobrazit plný text záznamu